Trader: Low Volume ...
Health Care: Drugs
Chelsea Therapeutics International Ltd. (CHTP: NASDAQ)
$1.35 0.00 | 0.00%
06/04/12 - 04:00 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Sales | -116.46K | -75.61K | -69.43K | -57.00K |
| Gross Operating Profit | 116.46K | 75.61K | 69.43K | 57.00K |
| Selling, General, and Administrative Expenses | 13.34M | 6.63M | 6.37M | 5.29M |
| Research & Development | 37.27M | 30.87M | 23.99M | 27.11M |
| Operating Income before D & A (EBITDA) | -50.50M | -37.43M | -30.28M | -32.34M |
| Depreciation & Amortization | 116.46K | 75.61K | 69.43K | 57.00K |
| Interest Income | 161.83K | 242.88K | 336.85K | 1.71M |
| Other Income - Net | 0.00 | 0.00 | 4.39M | -4.39M |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -50.45M | -37.26M | -25.62M | -35.08M |
| Interest Expense | 0.00 | 70.39K | 149.02K | 5.00K |
| Pre-Tax Income | -50.45M | -37.33M | -25.77M | -35.08M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -50.45M | -37.33M | -25.77M | -35.09M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -50.45M | -37.33M | -25.77M | -35.09M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -50.45M | -37.33M | -25.77M | -35.09M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-50.45M | -37.33M | -25.77M | -35.09M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -50.45M | -37.33M | -25.77M | -35.09M |
| Basic EPS from Continuing Ops. | -0.84 | -0.91 | -0.82 | -1.17 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.84 | -0.91 | -0.82 | -1.17 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.84 | -0.91 | -0.82 | -1.17 |
| Basic Normalized Net Income/Share | -0.84 | -0.91 | -0.82 | -1.17 |
| EPS fr Continuing Ops. | -0.84 | -0.91 | -0.82 | -1.17 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.84 | -0.91 | -0.82 | -1.17 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.84 | -0.91 | -0.82 | -1.17 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.84 | -0.91 | -0.82 | -1.17 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with CHTP
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- ContributorEarnings Short Squeeze Play...
- ContributorBreakout Stocks Of The Week...
- UserLA
- ContributorBreakout Stocks Of The Week...
- ContributorBreakout Stocks Of The Week...
- Contributor10 Pharma Stocks With 100% ...
- UserLIGDOGS
- UserSharebuilder
Latest CHTP Headlines from TheStreet
- Chelsea Therapeutics' CEO Discusses Completion Of EoR Meeting With FDA For Northera Capsules NDA (Transcript) 05.23.12 | 07:05 am
- Chelsea Therapeutics' CEO Discusses Chelsea Therapeutics Receives Complete Response Letter From Food And Drug Administration For Northera(TM) (droxidopa) Capsules (Transcript) 03.29.12 | 01:03 pm
- Biotech Stock Mailbag: Xoma's Big Backers, FDA Approvals Contest 03.23.12 | 05:03 am
- The Next Big Thing in Biotech: FDA Decisions
03.23.12 | 05:03 am - Biotech Stock Chat: Recap 03.15.12 | 11:03 am
- Chelsea Therapeutics International's CEO Discusses Q4 2011 Results - Earnings Call Transcript 03.06.12 | 07:03 pm
- Chelsea Therapeutics' CEO Presents FDA Advisory Committee Update - Conference Call (Transcript) 02.29.12 | 09:02 pm
- Wednesday's Top 10 Articles, Videos on TheStreet 02.29.12 | 01:02 pm
- Biotech Twitter Mailbag: Gilead, Chelsea, Keryx, Onyx, BioSante, Dendreon 02.29.12 | 06:02 am
- Monday's Top 10 Articles, Videos on TheStreet 02.27.12 | 02:02 pm
Press Releases for CHTP
- Faruqi & Faruqi, LLP Notifies Investors Of June 4, 2012 Lead Plaintiff Deadline For The Class Action Filed Against Chelsea Therapeutics International - PR Newswire 05.29.12 | 07:05 pm
- Chelsea Therapeutics International Lead Plaintiff Deadline - June 4, 2012: Levi & Korsinsky Reminds Investors With Losses On Their Investment In Chelsea Therapeutics International Of Class Action And The Lead Plaintiff Deadline - Business Wire 05.29.12 | 02:05 pm
- Upcoming Deadline: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In Chelsea Therapeutics International Ltd. Of Class Action Lawsuit And The Deadline Of June 4, 2012 To Seek A Lead Plaintiff Position - PR Newswire 05.21.12 | 02:05 pm
- Upcoming Deadline: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In Chelsea Therapeutics International Ltd. Of Class Action Lawsuit And The Deadline Of June 4, 2012 To Seek A Lead Plaintiff Position - Business Wire 04.30.12 | 04:04 pm
- Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In Chelsea Therapeutics International, Ltd. To Contact The Firm - PR Newswire 04.20.12 | 07:04 pm
- Chelsea Therapeutics International Shareholder Alert: The Briscoe Law Firm And Powers Taylor, LLP Investigate Possible Breaches Of Fiduciary Duty By The Officers And Directors Of Chelsea Therapeutics International, Ltd. - Business Wire 04.11.12 | 10:04 am
- Faruqi & Faruqi, LLP Announces Investigation Of Chelsea Therapeutics International, Ltd. - PR Newswire 04.05.12 | 07:04 pm
- Upcoming Deadline: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In Chelsea Therapeutics International Ltd. Of Class Action Lawsuit And The Deadline Of June 4, 2012 To Seek A Lead Plaintiff Position - Business Wire 04.05.12 | 04:04 pm
- Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Chelsea Therapeutics International, Ltd. - Business Wire 04.05.12 | 12:04 pm
- Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Chelsea Therapeutics International, Ltd. - Business Wire 02.21.12 | 08:02 am
Partner Headlines for CHTP
- How To Play Chelsea Therapeutics - Seeking Alpha 03.09.12 | 04:03 pm
- 5 High-Risk, High-Reward Biopharma Stocks - Seeking Alpha 02.14.12 | 09:02 am
- 12 Healthcare Companies Expecting Major February Catalysts - Seeking Alpha 02.01.12 | 07:02 am
- 10 Biotech Stocks With Strong Corporate Governance - Seeking Alpha 01.18.12 | 09:01 am
- Friday Options Recap - Seeking Alpha 12.23.11 | 03:12 pm
- 6 Biotechs That Could See Huge Gains (Like Inhibitex) - Seeking Alpha 11.11.11 | 09:11 am
- 5 Healthcare Stocks of Interest This Week - Seeking Alpha 07.27.11 | 09:07 am
- Top 30 Rallying Small Cap Stocks With Significant Institutional Buying - Seeking Alpha 06.29.11 | 09:06 am
- 10 Undervalued Biotech Stocks With Insider Buying - Seeking Alpha 06.23.11 | 06:06 am
- 6 Cash Rich Biotech Stocks With Catalysts - Seeking Alpha 04.08.11 | 08:04 am
